| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |